Contact
Please use this form to send email to PR contact of this press release:
Teneobio Doses First Patient in Phase 1 Study of TNB-383B for the Treatment of Patients with Multiple Myeloma
TO:
Please use this form to send email to PR contact of this press release:
Teneobio Doses First Patient in Phase 1 Study of TNB-383B for the Treatment of Patients with Multiple Myeloma
TO: